![Kiernan T. DeAngelis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kiernan T. DeAngelis
Technik-/Wissenschafts-/F&E-Leiter bei Humacyte Global, Inc.
Aktive Positionen von Kiernan T. DeAngelis
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Humacyte Global, Inc.
![]() Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2020 | - |
Karriereverlauf von Kiernan T. DeAngelis
Ehemalige bekannte Positionen von Kiernan T. DeAngelis
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
HUMACYTE, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2020 | 01.10.2021 |
ASTRAZENECA PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2017 | 01.09.2019 |
UNITED THERAPEUTICS CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2013 | 01.05.2017 |
Ausbildung von Kiernan T. DeAngelis
Brody School of Medicine | Doctorate Degree |
North Carolina State University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Vereinigtes Königreich | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 4 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
HUMACYTE, INC. | Health Technology |
ASTRAZENECA PLC | Health Technology |
UNITED THERAPEUTICS CORPORATION | Health Technology |
Private Unternehmen | 1 |
---|---|
Humacyte Global, Inc.
![]() Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC. | Health Technology |
- Börse
- Insiders
- Kiernan T. DeAngelis
- Erfahrung